Skip to main content
PMC home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1995 Sep 12;92(19):8552–8559. doi: 10.1073/pnas.92.19.8552

Genetic dissection of Alzheimer disease, a heterogeneous disorder.

G D Schellenberg 1
PMCID: PMC41005  PMID: 7567974

Abstract

The genetics of Alzheimer disease (AD) are complex and not completely understood. Mutations in the amyloid precursor protein gene (APP) can cause early-onset autosomal dominant AD. In vitro studies indicate that cells expressing mutant APPs overproduce pathogenic forms of the A beta peptide, the major component of AD amyloid. However, mutations in the APP gene are responsible for 5% or less of all early-onset familial AD. A locus on chromosome 14 is responsible for AD in other early-onset AD families and represents the most severe form of the disease in terms of age of onset and rate of decline. Attempts to identify the AD3 gene by positional cloning methods are underway. At least one additional early-onset AD locus remains to be located. In late-onset AD, the apolipoprotein E gene allele epsilon 4 is a risk factor for AD. This allele appears to act as a dose-dependent age-of-onset modifier. The epsilon 2 allele of this gene may be protective. Other late-onset susceptibility factors remain to be identified.

Full text

PDF
8552

Images in this article

8553Fig. 1
on p.8553
8555Fig. 2
on p.8555

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ali G., Wasco W., Cai X., Szabo P., Sheu K. F., Cooper A. J., Gaston S. M., Gusella J. F., Tanzi R. E., Blass J. P. Isolation, characterization, and mapping of gene encoding dihydrolipoyl succinyltransferase (E2k) of human alpha-ketoglutarate dehydrogenase complex. Somat Cell Mol Genet. 1994 Mar;20(2):99–105. doi: 10.1007/BF02290679. [DOI] [PubMed] [Google Scholar]
  2. Axelman K., Basun H., Winblad B., Lannfelt L. A large Swedish family with Alzheimer's disease with a codon 670/671 amyloid precursor protein mutation. A clinical and genealogical investigation. Arch Neurol. 1994 Dec;51(12):1193–1197. doi: 10.1001/archneur.1994.00540240037013. [DOI] [PubMed] [Google Scholar]
  3. Bird T. D., Lampe T. H., Nemens E. J., Miner G. W., Sumi S. M., Schellenberg G. D. Familial Alzheimer's disease in American descendants of the Volga Germans: probable genetic founder effect. Ann Neurol. 1988 Jan;23(1):25–31. doi: 10.1002/ana.410230106. [DOI] [PubMed] [Google Scholar]
  4. Bird T. D., Sumi S. M., Nemens E. J., Nochlin D., Schellenberg G., Lampe T. H., Sadovnick A., Chui H., Miner G. W., Tinklenberg J. Phenotypic heterogeneity in familial Alzheimer's disease: a study of 24 kindreds. Ann Neurol. 1989 Jan;25(1):12–25. doi: 10.1002/ana.410250104. [DOI] [PubMed] [Google Scholar]
  5. Bonnycastle L. L., Yu C. E., Hunt C. R., Trask B. J., Clancy K. P., Weber J. L., Patterson D., Schellenberg G. D. Cloning, sequencing, and mapping of the human chromosome 14 heat shock protein gene (HSPA2). Genomics. 1994 Sep 1;23(1):85–93. doi: 10.1006/geno.1994.1462. [DOI] [PubMed] [Google Scholar]
  6. Bonnycastle L. L., Yu C. E., Wijsman E. M., Orr H. T., Patterson D., Clancy K. P., Goddard K. A., Alonso M. E., Nemens E., White J. A. The c-fos gene and early-onset familial Alzheimer's disease. Neurosci Lett. 1993 Sep 17;160(1):33–36. doi: 10.1016/0304-3940(93)90910-d. [DOI] [PubMed] [Google Scholar]
  7. Boyles J. K., Notterpek L. M., Anderson L. J. Accumulation of apolipoproteins in the regenerating and remyelinating mammalian peripheral nerve. Identification of apolipoprotein D, apolipoprotein A-IV, apolipoprotein E, and apolipoprotein A-I. J Biol Chem. 1990 Oct 15;265(29):17805–17815. [PubMed] [Google Scholar]
  8. Boyles J. K., Zoellner C. D., Anderson L. J., Kosik L. M., Pitas R. E., Weisgraber K. H., Hui D. Y., Mahley R. W., Gebicke-Haerter P. J., Ignatius M. J. A role for apolipoprotein E, apolipoprotein A-I, and low density lipoprotein receptors in cholesterol transport during regeneration and remyelination of the rat sciatic nerve. J Clin Invest. 1989 Mar;83(3):1015–1031. doi: 10.1172/JCI113943. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Brousseau T., Legrain S., Berr C., Gourlet V., Vidal O., Amouyel P. Confirmation of the epsilon 4 allele of the apolipoprotein E gene as a risk factor for late-onset Alzheimer's disease. Neurology. 1994 Feb;44(2):342–344. doi: 10.1212/wnl.44.2.342. [DOI] [PubMed] [Google Scholar]
  10. Burdick D., Soreghan B., Kwon M., Kosmoski J., Knauer M., Henschen A., Yates J., Cotman C., Glabe C. Assembly and aggregation properties of synthetic Alzheimer's A4/beta amyloid peptide analogs. J Biol Chem. 1992 Jan 5;267(1):546–554. [PubMed] [Google Scholar]
  11. Cai X. D., Golde T. E., Younkin S. G. Release of excess amyloid beta protein from a mutant amyloid beta protein precursor. Science. 1993 Jan 22;259(5094):514–516. doi: 10.1126/science.8424174. [DOI] [PubMed] [Google Scholar]
  12. Chartier-Harlin M. C., Crawford F., Houlden H., Warren A., Hughes D., Fidani L., Goate A., Rossor M., Roques P., Hardy J. Early-onset Alzheimer's disease caused by mutations at codon 717 of the beta-amyloid precursor protein gene. Nature. 1991 Oct 31;353(6347):844–846. doi: 10.1038/353844a0. [DOI] [PubMed] [Google Scholar]
  13. Chartier-Harlin M. C., Parfitt M., Legrain S., Pérez-Tur J., Brousseau T., Evans A., Berr C., Vidal O., Roques P., Gourlet V. Apolipoprotein E, epsilon 4 allele as a major risk factor for sporadic early and late-onset forms of Alzheimer's disease: analysis of the 19q13.2 chromosomal region. Hum Mol Genet. 1994 Apr;3(4):569–574. doi: 10.1093/hmg/3.4.569. [DOI] [PubMed] [Google Scholar]
  14. Citron M., Oltersdorf T., Haass C., McConlogue L., Hung A. Y., Seubert P., Vigo-Pelfrey C., Lieberburg I., Selkoe D. J. Mutation of the beta-amyloid precursor protein in familial Alzheimer's disease increases beta-protein production. Nature. 1992 Dec 17;360(6405):672–674. doi: 10.1038/360672a0. [DOI] [PubMed] [Google Scholar]
  15. Citron M., Vigo-Pelfrey C., Teplow D. B., Miller C., Schenk D., Johnston J., Winblad B., Venizelos N., Lannfelt L., Selkoe D. J. Excessive production of amyloid beta-protein by peripheral cells of symptomatic and presymptomatic patients carrying the Swedish familial Alzheimer disease mutation. Proc Natl Acad Sci U S A. 1994 Dec 6;91(25):11993–11997. doi: 10.1073/pnas.91.25.11993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Corder E. H., Saunders A. M., Risch N. J., Strittmatter W. J., Schmechel D. E., Gaskell P. C., Jr, Rimmler J. B., Locke P. A., Conneally P. M., Schmader K. E. Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nat Genet. 1994 Jun;7(2):180–184. doi: 10.1038/ng0694-180. [DOI] [PubMed] [Google Scholar]
  17. Corder E. H., Saunders A. M., Strittmatter W. J., Schmechel D. E., Gaskell P. C., Small G. W., Roses A. D., Haines J. L., Pericak-Vance M. A. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science. 1993 Aug 13;261(5123):921–923. doi: 10.1126/science.8346443. [DOI] [PubMed] [Google Scholar]
  18. Dai X. Y., Nanko S., Hattori M., Fukuda R., Nagata K., Isse K., Ueki A., Kazamatsuri H. Association of apolipoprotein E4 with sporadic Alzheimer's disease is more pronounced in early onset type. Neurosci Lett. 1994 Jul 4;175(1-2):74–76. doi: 10.1016/0304-3940(94)91081-2. [DOI] [PubMed] [Google Scholar]
  19. Esch F. S., Keim P. S., Beattie E. C., Blacher R. W., Culwell A. R., Oltersdorf T., McClure D., Ward P. J. Cleavage of amyloid beta peptide during constitutive processing of its precursor. Science. 1990 Jun 1;248(4959):1122–1124. doi: 10.1126/science.2111583. [DOI] [PubMed] [Google Scholar]
  20. Evans D. A., Funkenstein H. H., Albert M. S., Scherr P. A., Cook N. R., Chown M. J., Hebert L. E., Hennekens C. H., Taylor J. O. Prevalence of Alzheimer's disease in a community population of older persons. Higher than previously reported. JAMA. 1989 Nov 10;262(18):2551–2556. [PubMed] [Google Scholar]
  21. Evans K. C., Berger E. P., Cho C. G., Weisgraber K. H., Lansbury P. T., Jr Apolipoprotein E is a kinetic but not a thermodynamic inhibitor of amyloid formation: implications for the pathogenesis and treatment of Alzheimer disease. Proc Natl Acad Sci U S A. 1995 Jan 31;92(3):763–767. doi: 10.1073/pnas.92.3.763. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. FELDMAN R. G., CHANDLER K. A., LEVY L. L., GLASER G. H. FAMILIAL ALZHEIMER'S DISEASE. Neurology. 1963 Oct;13:811–824. doi: 10.1212/wnl.13.10.811. [DOI] [PubMed] [Google Scholar]
  23. Farlow M., Murrell J., Ghetti B., Unverzagt F., Zeldenrust S., Benson M. Clinical characteristics in a kindred with early-onset Alzheimer's disease and their linkage to a G-->T change at position 2149 of the amyloid precursor protein gene. Neurology. 1994 Jan;44(1):105–111. doi: 10.1212/wnl.44.1.105. [DOI] [PubMed] [Google Scholar]
  24. Fidani L., Rooke K., Chartier-Harlin M. C., Hughes D., Tanzi R., Mullan M., Roques P., Rossor M., Hardy J., Goate A. Screening for mutations in the open reading frame and promoter of the beta-amyloid precursor protein gene in familial Alzheimer's disease: identification of a further family with APP717 Val-->Ile. Hum Mol Genet. 1992 Jun;1(3):165–168. doi: 10.1093/hmg/1.3.165. [DOI] [PubMed] [Google Scholar]
  25. Frommelt P., Schnabel R., Kühne W., Nee L. E., Polinsky R. J. Familial Alzheimer disease: a large, multigeneration German kindred. Alzheimer Dis Assoc Disord. 1991 Spring;5(1):36–43. doi: 10.1097/00002093-199100510-00005. [DOI] [PubMed] [Google Scholar]
  26. Glenner G. G., Wong C. W. Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun. 1984 May 16;120(3):885–890. doi: 10.1016/s0006-291x(84)80190-4. [DOI] [PubMed] [Google Scholar]
  27. Goate A. M., Haynes A. R., Owen M. J., Farrall M., James L. A., Lai L. Y., Mullan M. J., Roques P., Rossor M. N., Williamson R. Predisposing locus for Alzheimer's disease on chromosome 21. Lancet. 1989 Feb 18;1(8634):352–355. doi: 10.1016/s0140-6736(89)91725-x. [DOI] [PubMed] [Google Scholar]
  28. Goate A., Chartier-Harlin M. C., Mullan M., Brown J., Crawford F., Fidani L., Giuffra L., Haynes A., Irving N., James L. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature. 1991 Feb 21;349(6311):704–706. doi: 10.1038/349704a0. [DOI] [PubMed] [Google Scholar]
  29. Goudsmit J., White B. J., Weitkamp L. R., Keats B. J., Morrow C. H., Gajdusek D. C. Familial Alzheimer's disease in two kindreds of the same geographic and ethnic origin. A clinical and genetic study. J Neurol Sci. 1981 Jan;49(1):79–89. doi: 10.1016/0022-510x(81)90190-8. [DOI] [PubMed] [Google Scholar]
  30. Haan J., Roos R. A., Bakker E. No protective effect of apolipoprotein E epsilon 2 allele in Dutch hereditary cerebral amyloid angiopathy. Ann Neurol. 1995 Feb;37(2):282–282. doi: 10.1002/ana.410370223. [DOI] [PubMed] [Google Scholar]
  31. Haan J., Van Broeckhoven C., van Duijn C. M., Voorhoeve E., van Harskamp F., van Swieten J. C., Maat-Schieman M. L., Roos R. A., Bakker E. The apolipoprotein E epsilon 4 allele does not influence the clinical expression of the amyloid precursor protein gene codon 693 or 692 mutations. Ann Neurol. 1994 Sep;36(3):434–437. doi: 10.1002/ana.410360315. [DOI] [PubMed] [Google Scholar]
  32. Haass C., Hung A. Y., Selkoe D. J., Teplow D. B. Mutations associated with a locus for familial Alzheimer's disease result in alternative processing of amyloid beta-protein precursor. J Biol Chem. 1994 Jul 1;269(26):17741–17748. [PubMed] [Google Scholar]
  33. Haass C., Schlossmacher M. G., Hung A. Y., Vigo-Pelfrey C., Mellon A., Ostaszewski B. L., Lieberburg I., Koo E. H., Schenk D., Teplow D. B. Amyloid beta-peptide is produced by cultured cells during normal metabolism. Nature. 1992 Sep 24;359(6393):322–325. doi: 10.1038/359322a0. [DOI] [PubMed] [Google Scholar]
  34. Haltia M., Viitanen M., Sulkava R., Ala-Hurula V., Poyhonen M., Goldfarb L., Brown P., Levy E., Houlden H., Crook R. Chromosome 14-encoded Alzheimer's disease: genetic and clinicopathological description. Ann Neurol. 1994 Sep;36(3):362–367. doi: 10.1002/ana.410360307. [DOI] [PubMed] [Google Scholar]
  35. Hendrie H. C., Hall K. S., Hui S., Unverzagt F. W., Yu C. E., Lahiri D. K., Sahota A., Farlow M., Musick B., Class C. A. Apolipoprotein E genotypes and Alzheimer's disease in a community study of elderly African Americans. Ann Neurol. 1995 Jan;37(1):118–120. doi: 10.1002/ana.410370123. [DOI] [PubMed] [Google Scholar]
  36. Hendriks L., van Duijn C. M., Cras P., Cruts M., Van Hul W., van Harskamp F., Warren A., McInnis M. G., Antonarakis S. E., Martin J. J. Presenile dementia and cerebral haemorrhage linked to a mutation at codon 692 of the beta-amyloid precursor protein gene. Nat Genet. 1992 Jun;1(3):218–221. doi: 10.1038/ng0692-218. [DOI] [PubMed] [Google Scholar]
  37. Hilbich C., Kisters-Woike B., Reed J., Masters C. L., Beyreuther K. Aggregation and secondary structure of synthetic amyloid beta A4 peptides of Alzheimer's disease. J Mol Biol. 1991 Mar 5;218(1):149–163. doi: 10.1016/0022-2836(91)90881-6. [DOI] [PubMed] [Google Scholar]
  38. Houlden H., Crawford F., Rossor M., Mullan M. Screening for the APP codon 670/671 mutations in Alzheimer's disease. Neurosci Lett. 1993 May 14;154(1-2):161–162. doi: 10.1016/0304-3940(93)90196-r. [DOI] [PubMed] [Google Scholar]
  39. Houlden H., Crook R., Hardy J., Roques P., Collinge J., Rossor M. Confirmation that familial clustering and age of onset in late onset Alzheimer's disease are determined at the apolipoprotein E locus. Neurosci Lett. 1994 Jun 20;174(2):222–224. doi: 10.1016/0304-3940(94)90026-4. [DOI] [PubMed] [Google Scholar]
  40. Ignatius M. J., Shooter E. M., Pitas R. E., Mahley R. W. Lipoprotein uptake by neuronal growth cones in vitro. Science. 1987 May 22;236(4804):959–962. doi: 10.1126/science.3576212. [DOI] [PubMed] [Google Scholar]
  41. Jacobsen J. S., Muenkel H. A., Blume A. J., Vitek M. P. A novel species-specific RNA related to alternatively spliced amyloid precursor protein mRNAs. Neurobiol Aging. 1991 Sep-Oct;12(5):575–583. doi: 10.1016/0197-4580(91)90089-3. [DOI] [PubMed] [Google Scholar]
  42. Jarrett J. T., Lansbury P. T., Jr Seeding "one-dimensional crystallization" of amyloid: a pathogenic mechanism in Alzheimer's disease and scrapie? Cell. 1993 Jun 18;73(6):1055–1058. doi: 10.1016/0092-8674(93)90635-4. [DOI] [PubMed] [Google Scholar]
  43. Kamino K., Orr H. T., Payami H., Wijsman E. M., Alonso M. E., Pulst S. M., Anderson L., O'dahl S., Nemens E., White J. A. Linkage and mutational analysis of familial Alzheimer disease kindreds for the APP gene region. Am J Hum Genet. 1992 Nov;51(5):998–1014. [PMC free article] [PubMed] [Google Scholar]
  44. Kang J., Lemaire H. G., Unterbeck A., Salbaum J. M., Masters C. L., Grzeschik K. H., Multhaup G., Beyreuther K., Müller-Hill B. The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature. 1987 Feb 19;325(6106):733–736. doi: 10.1038/325733a0. [DOI] [PubMed] [Google Scholar]
  45. Kennedy A. M., Newman S., McCaddon A., Ball J., Roques P., Mullan M., Hardy J., Chartier-Harlin M. C., Frackowiak R. S., Warrington E. K. Familial Alzheimer's disease. A pedigree with a mis-sense mutation in the amyloid precursor protein gene (amyloid precursor protein 717 valine-->glycine). Brain. 1993 Apr;116(Pt 2):309–324. doi: 10.1093/brain/116.2.309. [DOI] [PubMed] [Google Scholar]
  46. Kitaguchi N., Takahashi Y., Tokushima Y., Shiojiri S., Ito H. Novel precursor of Alzheimer's disease amyloid protein shows protease inhibitory activity. Nature. 1988 Feb 11;331(6156):530–532. doi: 10.1038/331530a0. [DOI] [PubMed] [Google Scholar]
  47. Kuusisto J., Koivisto K., Kervinen K., Mykkänen L., Helkala E. L., Vanhanen M., Hänninen T., Pyörälä K., Kesäniemi Y. A., Riekkinen P. Association of apolipoprotein E phenotypes with late onset Alzheimer's disease: population based study. BMJ. 1994 Sep 10;309(6955):636–638. doi: 10.1136/bmj.309.6955.636. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. König G., Mönning U., Czech C., Prior R., Banati R., Schreiter-Gasser U., Bauer J., Masters C. L., Beyreuther K. Identification and differential expression of a novel alternative splice isoform of the beta A4 amyloid precursor protein (APP) mRNA in leukocytes and brain microglial cells. J Biol Chem. 1992 May 25;267(15):10804–10809. [PubMed] [Google Scholar]
  49. L'Hernault S. W., Arduengo P. M. Mutation of a putative sperm membrane protein in Caenorhabditis elegans prevents sperm differentiation but not its associated meiotic divisions. J Cell Biol. 1992 Oct;119(1):55–68. doi: 10.1083/jcb.119.1.55. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. LaDu M. J., Falduto M. T., Manelli A. M., Reardon C. A., Getz G. S., Frail D. E. Isoform-specific binding of apolipoprotein E to beta-amyloid. J Biol Chem. 1994 Sep 23;269(38):23403–23406. [PubMed] [Google Scholar]
  51. Lampe T. H., Bird T. D., Nochlin D., Nemens E., Risse S. C., Sumi S. M., Koerker R., Leaird B., Wier M., Raskind M. A. Phenotype of chromosome 14-linked familial Alzheimer's disease in a large kindred. Ann Neurol. 1994 Sep;36(3):368–378. doi: 10.1002/ana.410360308. [DOI] [PubMed] [Google Scholar]
  52. Lannfelt L., Lilius L., Appelgren H., Axelman K., Forsell C., Liu L., Johansson K., Graff C. No linkage to chromosome 14 in Swedish Alzheimer's disease families. Nat Genet. 1993 Jul;4(3):218–219. doi: 10.1038/ng0793-218. [DOI] [PubMed] [Google Scholar]
  53. Lemaire H. G., Salbaum J. M., Multhaup G., Kang J., Bayney R. M., Unterbeck A., Beyreuther K., Müller-Hill B. The PreA4(695) precursor protein of Alzheimer's disease A4 amyloid is encoded by 16 exons. Nucleic Acids Res. 1989 Jan 25;17(2):517–522. doi: 10.1093/nar/17.2.517. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Levy E., Carman M. D., Fernandez-Madrid I. J., Power M. D., Lieberburg I., van Duinen S. G., Bots G. T., Luyendijk W., Frangione B. Mutation of the Alzheimer's disease amyloid gene in hereditary cerebral hemorrhage, Dutch type. Science. 1990 Jun 1;248(4959):1124–1126. doi: 10.1126/science.2111584. [DOI] [PubMed] [Google Scholar]
  55. Liddell M., Williams J., Bayer A., Kaiser F., Owen M. Confirmation of association between the e4 allele of apolipoprotein E and Alzheimer's disease. J Med Genet. 1994 Mar;31(3):197–200. doi: 10.1136/jmg.31.3.197. [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. Locke P. A., Conneally P. M., Tanzi R. E., Gusella J. F., Haines J. L. Apolipoprotein E4 allele and Alzheimer disease: examination of allelic association and effect on age at onset in both early- and late-onset cases. Genet Epidemiol. 1995;12(1):83–92. doi: 10.1002/gepi.1370120108. [DOI] [PubMed] [Google Scholar]
  57. Lucotte G., Turpin J. C., Landais P. Apolipoprotein E-epsilon 4 allele doses in late-onset Alzheimer's disease. Ann Neurol. 1994 Oct;36(4):681–682. doi: 10.1002/ana.410360429. [DOI] [PubMed] [Google Scholar]
  58. Ma J., Yee A., Brewer H. B., Jr, Das S., Potter H. Amyloid-associated proteins alpha 1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer beta-protein into filaments. Nature. 1994 Nov 3;372(6501):92–94. doi: 10.1038/372092a0. [DOI] [PubMed] [Google Scholar]
  59. Maestre G., Ottman R., Stern Y., Gurland B., Chun M., Tang M. X., Shelanski M., Tycko B., Mayeux R. Apolipoprotein E and Alzheimer's disease: ethnic variation in genotypic risks. Ann Neurol. 1995 Feb;37(2):254–259. doi: 10.1002/ana.410370217. [DOI] [PubMed] [Google Scholar]
  60. Mahley R. W. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science. 1988 Apr 29;240(4852):622–630. doi: 10.1126/science.3283935. [DOI] [PubMed] [Google Scholar]
  61. Martin J. J., Gheuens J., Bruyland M., Cras P., Vandenberghe A., Masters C. L., Beyreuther K., Dom R., Ceuterick C., Lübke U. Early-onset Alzheimer's disease in 2 large Belgian families. Neurology. 1991 Jan;41(1):62–68. doi: 10.1212/wnl.41.1.62. [DOI] [PubMed] [Google Scholar]
  62. Masters C. L., Simms G., Weinman N. A., Multhaup G., McDonald B. L., Beyreuther K. Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc Natl Acad Sci U S A. 1985 Jun;82(12):4245–4249. doi: 10.1073/pnas.82.12.4245. [DOI] [PMC free article] [PubMed] [Google Scholar]
  63. Mayeux R., Stern Y., Ottman R., Tatemichi T. K., Tang M. X., Maestre G., Ngai C., Tycko B., Ginsberg H. The apolipoprotein epsilon 4 allele in patients with Alzheimer's disease. Ann Neurol. 1993 Nov;34(5):752–754. doi: 10.1002/ana.410340527. [DOI] [PubMed] [Google Scholar]
  64. McGeer P. L., Rogers J. Anti-inflammatory agents as a therapeutic approach to Alzheimer's disease. Neurology. 1992 Feb;42(2):447–449. doi: 10.1212/wnl.42.2.447. [DOI] [PubMed] [Google Scholar]
  65. Mitsunaga Y., Takahashi K., Tabira T., Tasaki H., Watanabe S. Assignment of a familial Alzheimer's disease locus between D14S289 and D14S53. Lancet. 1994 Oct 22;344(8930):1154–1155. doi: 10.1016/s0140-6736(94)90660-2. [DOI] [PubMed] [Google Scholar]
  66. Mullan M., Crawford F., Axelman K., Houlden H., Lilius L., Winblad B., Lannfelt L. A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N-terminus of beta-amyloid. Nat Genet. 1992 Aug;1(5):345–347. doi: 10.1038/ng0892-345. [DOI] [PubMed] [Google Scholar]
  67. Mullan M., Houlden H., Crawford F., Kennedy A., Rogues P., Rossor M. Age of onset in familial early onset Alzheimer's disease correlates with genetic aetiology. Am J Med Genet. 1993 Oct 15;48(3):129–130. doi: 10.1002/ajmg.1320480303. [DOI] [PubMed] [Google Scholar]
  68. Mullan M., Houlden H., Windelspecht M., Fidani L., Lombardi C., Diaz P., Rossor M., Crook R., Hardy J., Duff K. A locus for familial early-onset Alzheimer's disease on the long arm of chromosome 14, proximal to the alpha 1-antichymotrypsin gene. Nat Genet. 1992 Dec;2(4):340–342. doi: 10.1038/ng1292-340. [DOI] [PubMed] [Google Scholar]
  69. Mullan M., Tsuji S., Miki T., Katsuya T., Naruse S., Kaneko K., Shimizu T., Kojima T., Nakano I., Ogihara T. Clinical comparison of Alzheimer's disease in pedigrees with the codon 717 Val-->Ile mutation in the amyloid precursor protein gene. Neurobiol Aging. 1993 Sep-Oct;14(5):407–419. doi: 10.1016/0197-4580(93)90099-w. [DOI] [PubMed] [Google Scholar]
  70. Murrell J., Farlow M., Ghetti B., Benson M. D. A mutation in the amyloid precursor protein associated with hereditary Alzheimer's disease. Science. 1991 Oct 4;254(5028):97–99. doi: 10.1126/science.1925564. [DOI] [PubMed] [Google Scholar]
  71. Naruse S., Igarashi S., Kobayashi H., Aoki K., Inuzuka T., Kaneko K., Shimizu T., Iihara K., Kojima T., Miyatake T. Mis-sense mutation Val----Ile in exon 17 of amyloid precursor protein gene in Japanese familial Alzheimer's disease. Lancet. 1991 Apr 20;337(8747):978–979. doi: 10.1016/0140-6736(91)91612-x. [DOI] [PubMed] [Google Scholar]
  72. Nathan B. P., Bellosta S., Sanan D. A., Weisgraber K. H., Mahley R. W., Pitas R. E. Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro. Science. 1994 May 6;264(5160):850–852. doi: 10.1126/science.8171342. [DOI] [PubMed] [Google Scholar]
  73. Nechiporuk A., Fain P., Kort E., Nee L. E., Frommelt E., Polinsky R. J., Korenberg J. R., Pulst S. M. Linkage of familial Alzheimer disease to chromosome 14 in two large early-onset pedigrees: effects of marker allele frequencies on lod scores. Am J Med Genet. 1993 May 1;48(1):63–66. doi: 10.1002/ajmg.1320480113. [DOI] [PubMed] [Google Scholar]
  74. Nee L. E., Polinsky R. J., Eldridge R., Weingartner H., Smallberg S., Ebert M. A family with histologically confirmed Alzheimer's disease. Arch Neurol. 1983 Apr;40(4):203–208. doi: 10.1001/archneur.1983.04050040033004. [DOI] [PubMed] [Google Scholar]
  75. Noguchi S., Murakami K., Yamada N. Apolipoprotein E genotype and Alzheimer's disease. Lancet. 1993 Sep 18;342(8873):737–737. doi: 10.1016/0140-6736(93)91728-5. [DOI] [PubMed] [Google Scholar]
  76. Oliver C., Holland A. J. Down's syndrome and Alzheimer's disease: a review. Psychol Med. 1986 May;16(2):307–322. doi: 10.1017/s0033291700009120. [DOI] [PubMed] [Google Scholar]
  77. Payami H., Kaye J., Heston L. L., Bird T. D., Schellenberg G. D. Apolipoprotein E genotype and Alzheimer's disease. Lancet. 1993 Sep 18;342(8873):738–738. [PubMed] [Google Scholar]
  78. Payami H., Montee K. R., Kaye J. A., Bird T. D., Yu C. E., Wijsman E. M., Schellenberg G. D. Alzheimer's disease, apolipoprotein E4, and gender. JAMA. 1994 May 4;271(17):1316–1317. [PubMed] [Google Scholar]
  79. Pericak-Vance M. A., Bebout J. L., Gaskell P. C., Jr, Yamaoka L. H., Hung W. Y., Alberts M. J., Walker A. P., Bartlett R. J., Haynes C. A., Welsh K. A. Linkage studies in familial Alzheimer disease: evidence for chromosome 19 linkage. Am J Hum Genet. 1991 Jun;48(6):1034–1050. [PMC free article] [PubMed] [Google Scholar]
  80. Pericak-Vance M. A., Yamaoka L. H., Haynes C. S., Speer M. C., Haines J. L., Gaskell P. C., Hung W. Y., Clark C. M., Heyman A. L., Trofatter J. A. Genetic linkage studies in Alzheimer's disease families. Exp Neurol. 1988 Dec;102(3):271–279. doi: 10.1016/0014-4886(88)90220-8. [DOI] [PubMed] [Google Scholar]
  81. Poirier J. Apolipoprotein E in animal models of CNS injury and in Alzheimer's disease. Trends Neurosci. 1994 Dec;17(12):525–530. doi: 10.1016/0166-2236(94)90156-2. [DOI] [PubMed] [Google Scholar]
  82. Poirier J., Davignon J., Bouthillier D., Kogan S., Bertrand P., Gauthier S. Apolipoprotein E polymorphism and Alzheimer's disease. Lancet. 1993 Sep 18;342(8873):697–699. doi: 10.1016/0140-6736(93)91705-q. [DOI] [PubMed] [Google Scholar]
  83. Poirier J., Hess M., May P. C., Finch C. E. Astrocytic apolipoprotein E mRNA and GFAP mRNA in hippocampus after entorhinal cortex lesioning. Brain Res Mol Brain Res. 1991 Sep;11(2):97–106. doi: 10.1016/0169-328x(91)90111-a. [DOI] [PubMed] [Google Scholar]
  84. Ponte P., Gonzalez-DeWhitt P., Schilling J., Miller J., Hsu D., Greenberg B., Davis K., Wallace W., Lieberburg I., Fuller F. A new A4 amyloid mRNA contains a domain homologous to serine proteinase inhibitors. Nature. 1988 Feb 11;331(6156):525–527. doi: 10.1038/331525a0. [DOI] [PubMed] [Google Scholar]
  85. Rebeck G. W., Reiter J. S., Strickland D. K., Hyman B. T. Apolipoprotein E in sporadic Alzheimer's disease: allelic variation and receptor interactions. Neuron. 1993 Oct;11(4):575–580. doi: 10.1016/0896-6273(93)90070-8. [DOI] [PubMed] [Google Scholar]
  86. Risse S. C., Lampe T. H., Bird T. D., Nochlin D., Sumi S. M., Keenan T., Cubberley L., Peskind E., Raskind M. A. Myoclonus, seizures, and paratonia in Alzheimer disease. Alzheimer Dis Assoc Disord. 1990 Winter;4(4):217–225. doi: 10.1097/00002093-199040400-00003. [DOI] [PubMed] [Google Scholar]
  87. Rogaev E. I., Lukiw W. J., Vaula G., Haines J. L., Rogaeva E. A., Tsuda T., Alexandrova N., Liang Y., Mortilla M., Amaducci L. Analysis of the c-FOS gene on chromosome 14 and the promoter of the amyloid precursor protein gene in familial Alzheimer's disease. Neurology. 1993 Nov;43(11):2275–2279. doi: 10.1212/wnl.43.11.2275. [DOI] [PubMed] [Google Scholar]
  88. Sandbrink R., Masters C. L., Beyreuther K. Beta A4-amyloid protein precursor mRNA isoforms without exon 15 are ubiquitously expressed in rat tissues including brain, but not in neurons. J Biol Chem. 1994 Jan 14;269(2):1510–1517. [PubMed] [Google Scholar]
  89. Saunders A. M., Schmader K., Breitner J. C., Benson M. D., Brown W. T., Goldfarb L., Goldgaber D., Manwaring M. G., Szymanski M. H., McCown N. Apolipoprotein E epsilon 4 allele distributions in late-onset Alzheimer's disease and in other amyloid-forming diseases. Lancet. 1993 Sep 18;342(8873):710–711. doi: 10.1016/0140-6736(93)91709-u. [DOI] [PubMed] [Google Scholar]
  90. Saunders A. M., Strittmatter W. J., Schmechel D., George-Hyslop P. H., Pericak-Vance M. A., Joo S. H., Rosi B. L., Gusella J. F., Crapper-MacLachlan D. R., Alberts M. J. Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease. Neurology. 1993 Aug;43(8):1467–1472. doi: 10.1212/wnl.43.8.1467. [DOI] [PubMed] [Google Scholar]
  91. Schellenberg G. D., Anderson L., O'dahl S., Wisjman E. M., Sadovnick A. D., Ball M. J., Larson E. B., Kukull W. A., Martin G. M., Roses A. D. APP717, APP693, and PRIP gene mutations are rare in Alzheimer disease. Am J Hum Genet. 1991 Sep;49(3):511–517. [PMC free article] [PubMed] [Google Scholar]
  92. Schellenberg G. D., Bird T. D., Wijsman E. M., Moore D. K., Boehnke M., Bryant E. M., Lampe T. H., Nochlin D., Sumi S. M., Deeb S. S. Absence of linkage of chromosome 21q21 markers to familial Alzheimer's disease. Science. 1988 Sep 16;241(4872):1507–1510. doi: 10.1126/science.3420406. [DOI] [PubMed] [Google Scholar]
  93. Schellenberg G. D., Bird T. D., Wijsman E. M., Orr H. T., Anderson L., Nemens E., White J. A., Bonnycastle L., Weber J. L., Alonso M. E. Genetic linkage evidence for a familial Alzheimer's disease locus on chromosome 14. Science. 1992 Oct 23;258(5082):668–671. doi: 10.1126/science.1411576. [DOI] [PubMed] [Google Scholar]
  94. Schellenberg G. D., Boehnke M., Wijsman E. M., Moore D. K., Martin G. M., Bird T. D. Genetic association and linkage analysis of the apolipoprotein CII locus and familial Alzheimer's disease. Ann Neurol. 1992 Feb;31(2):223–227. doi: 10.1002/ana.410310214. [DOI] [PubMed] [Google Scholar]
  95. Schellenberg G. D., Deeb S. S., Boehnke M., Bryant E. M., Martin G. M., Lampe T. H., Bird T. D. Association of an apolipoprotein CII allele with familial dementia of the Alzheimer type. J Neurogenet. 1987 Apr;4(2-3):97–108. [PubMed] [Google Scholar]
  96. Schellenberg G. D., Payami H., Wijsman E. M., Orr H. T., Goddard K. A., Anderson L., Nemens E., White J. A., Alonso M. E., Ball M. J. Chromosome 14 and late-onset familial Alzheimer disease (FAD). Am J Hum Genet. 1993 Sep;53(3):619–628. [PMC free article] [PubMed] [Google Scholar]
  97. Schellenberg G. D., Pericak-Vance M. A., Wijsman E. M., Moore D. K., Gaskell P. C., Jr, Yamaoka L. A., Bebout J. L., Anderson L., Welsh K. A., Clark C. M. Linkage analysis of familial Alzheimer disease, using chromosome 21 markers. Am J Hum Genet. 1991 Mar;48(3):563–583. [PMC free article] [PubMed] [Google Scholar]
  98. Seubert P., Vigo-Pelfrey C., Esch F., Lee M., Dovey H., Davis D., Sinha S., Schlossmacher M., Whaley J., Swindlehurst C. Isolation and quantification of soluble Alzheimer's beta-peptide from biological fluids. Nature. 1992 Sep 24;359(6393):325–327. doi: 10.1038/359325a0. [DOI] [PubMed] [Google Scholar]
  99. Sherrington R., Rogaev E. I., Liang Y., Rogaeva E. A., Levesque G., Ikeda M., Chi H., Lin C., Li G., Holman K. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature. 1995 Jun 29;375(6534):754–760. doi: 10.1038/375754a0. [DOI] [PubMed] [Google Scholar]
  100. Shoji M., Golde T. E., Ghiso J., Cheung T. T., Estus S., Shaffer L. M., Cai X. D., McKay D. M., Tintner R., Frangione B. Production of the Alzheimer amyloid beta protein by normal proteolytic processing. Science. 1992 Oct 2;258(5079):126–129. doi: 10.1126/science.1439760. [DOI] [PubMed] [Google Scholar]
  101. Sisodia S. S., Koo E. H., Beyreuther K., Unterbeck A., Price D. L. Evidence that beta-amyloid protein in Alzheimer's disease is not derived by normal processing. Science. 1990 Apr 27;248(4954):492–495. doi: 10.1126/science.1691865. [DOI] [PubMed] [Google Scholar]
  102. Slunt H. H., Thinakaran G., Von Koch C., Lo A. C., Tanzi R. E., Sisodia S. S. Expression of a ubiquitous, cross-reactive homologue of the mouse beta-amyloid precursor protein (APP). J Biol Chem. 1994 Jan 28;269(4):2637–2644. [PubMed] [Google Scholar]
  103. Sorbi S., Nacmias B., Forleo P., Piacentini S., Amaducci L., Provinciali L. APP717 and Alzheimer's disease in Italy. Nat Genet. 1993 May;4(1):10–10. doi: 10.1038/ng0593-10. [DOI] [PubMed] [Google Scholar]
  104. St George-Hyslop P. H., Haines J. L., Farrer L. A., Polinsky R., Van Broeckhoven C., Goate A., McLachlan D. R., Orr H., Bruni A. C., Sorbi S. Genetic linkage studies suggest that Alzheimer's disease is not a single homogeneous disorder. Nature. 1990 Sep 13;347(6289):194–197. doi: 10.1038/347194a0. [DOI] [PubMed] [Google Scholar]
  105. St George-Hyslop P. H., Tanzi R. E., Polinsky R. J., Haines J. L., Nee L., Watkins P. C., Myers R. H., Feldman R. G., Pollen D., Drachman D. The genetic defect causing familial Alzheimer's disease maps on chromosome 21. Science. 1987 Feb 20;235(4791):885–890. doi: 10.1126/science.2880399. [DOI] [PubMed] [Google Scholar]
  106. St George-Hyslop P., Haines J., Rogaev E., Mortilla M., Vaula G., Pericak-Vance M., Foncin J. F., Montesi M., Bruni A., Sorbi S. Genetic evidence for a novel familial Alzheimer's disease locus on chromosome 14. Nat Genet. 1992 Dec;2(4):330–334. doi: 10.1038/ng1292-330. [DOI] [PubMed] [Google Scholar]
  107. St George-Hyslop P., McLachlan D. C., Tsuda T., Rogaev E., Karlinsky H., Lippa C. F., Pollen D., Tuda T. Alzheimer's disease and possible gene interaction. Science. 1994 Jan 28;263(5146):537–537. doi: 10.1126/science.8290965. [DOI] [PubMed] [Google Scholar]
  108. Strittmatter W. J., Saunders A. M., Goedert M., Weisgraber K. H., Dong L. M., Jakes R., Huang D. Y., Pericak-Vance M., Schmechel D., Roses A. D. Isoform-specific interactions of apolipoprotein E with microtubule-associated protein tau: implications for Alzheimer disease. Proc Natl Acad Sci U S A. 1994 Nov 8;91(23):11183–11186. doi: 10.1073/pnas.91.23.11183. [DOI] [PMC free article] [PubMed] [Google Scholar]
  109. Strittmatter W. J., Saunders A. M., Schmechel D., Pericak-Vance M., Enghild J., Salvesen G. S., Roses A. D. Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci U S A. 1993 Mar 1;90(5):1977–1981. doi: 10.1073/pnas.90.5.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  110. Strittmatter W. J., Weisgraber K. H., Huang D. Y., Dong L. M., Salvesen G. S., Pericak-Vance M., Schmechel D., Saunders A. M., Goldgaber D., Roses A. D. Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease. Proc Natl Acad Sci U S A. 1993 Sep 1;90(17):8098–8102. doi: 10.1073/pnas.90.17.8098. [DOI] [PMC free article] [PubMed] [Google Scholar]
  111. Struble R. G., Polinsky R. J., Hedreen J. C., Nee L. E., Frommelt P., Feldman R. G., Price D. L. Hippocampal lesions in dominantly inherited Alzheimer's disease. J Neuropathol Exp Neurol. 1991 Jan;50(1):82–94. doi: 10.1097/00005072-199101000-00007. [DOI] [PubMed] [Google Scholar]
  112. Suzuki N., Cheung T. T., Cai X. D., Odaka A., Otvos L., Jr, Eckman C., Golde T. E., Younkin S. G. An increased percentage of long amyloid beta protein secreted by familial amyloid beta protein precursor (beta APP717) mutants. Science. 1994 May 27;264(5163):1336–1340. doi: 10.1126/science.8191290. [DOI] [PubMed] [Google Scholar]
  113. Tamaoka A., Odaka A., Ishibashi Y., Usami M., Sahara N., Suzuki N., Nukina N., Mizusawa H., Shoji S., Kanazawa I. APP717 missense mutation affects the ratio of amyloid beta protein species (A beta 1-42/43 and a beta 1-40) in familial Alzheimer's disease brain. J Biol Chem. 1994 Dec 30;269(52):32721–32724. [PubMed] [Google Scholar]
  114. Tanzi R. E., George-Hyslop P. S., Gusella J. F. Molecular genetics of Alzheimer disease amyloid. J Biol Chem. 1991 Nov 5;266(31):20579–20582. [PubMed] [Google Scholar]
  115. Tanzi R. E., Gusella J. F., Watkins P. C., Bruns G. A., St George-Hyslop P., Van Keuren M. L., Patterson D., Pagan S., Kurnit D. M., Neve R. L. Amyloid beta protein gene: cDNA, mRNA distribution, and genetic linkage near the Alzheimer locus. Science. 1987 Feb 20;235(4791):880–884. doi: 10.1126/science.2949367. [DOI] [PubMed] [Google Scholar]
  116. Tanzi R. E., McClatchey A. I., Lamperti E. D., Villa-Komaroff L., Gusella J. F., Neve R. L. Protease inhibitor domain encoded by an amyloid protein precursor mRNA associated with Alzheimer's disease. Nature. 1988 Feb 11;331(6156):528–530. doi: 10.1038/331528a0. [DOI] [PubMed] [Google Scholar]
  117. Tanzi R. E., St George-Hyslop P. H., Haines J. L., Polinsky R. J., Nee L., Foncin J. F., Neve R. L., McClatchey A. I., Conneally P. M., Gusella J. F. The genetic defect in familial Alzheimer's disease is not tightly linked to the amyloid beta-protein gene. Nature. 1987 Sep 10;329(6135):156–157. doi: 10.1038/329156a0. [DOI] [PubMed] [Google Scholar]
  118. Tanzi R. E., Vaula G., Romano D. M., Mortilla M., Huang T. L., Tupler R. G., Wasco W., Hyman B. T., Haines J. L., Jenkins B. J. Assessment of amyloid beta-protein precursor gene mutations in a large set of familial and sporadic Alzheimer disease cases. Am J Hum Genet. 1992 Aug;51(2):273–282. [PMC free article] [PubMed] [Google Scholar]
  119. Tsai M. S., Tangalos E. G., Petersen R. C., Smith G. E., Schaid D. J., Kokmen E., Ivnik R. J., Thibodeau S. N. Apolipoprotein E: risk factor for Alzheimer disease. Am J Hum Genet. 1994 Apr;54(4):643–649. [PMC free article] [PubMed] [Google Scholar]
  120. Tsuda T., Lopez R., Rogaeva E. A., Freedman M., Rogaev E., Drachman D., Pollen D., Haines J., Liang Y., McLachlan D. R. Are the associations between Alzheimer's disease and polymorphisms in the apolipoprotein E and the apolipoprotein CII genes due to linkage disequilibrium? Ann Neurol. 1994 Jul;36(1):97–100. doi: 10.1002/ana.410360118. [DOI] [PubMed] [Google Scholar]
  121. Ueki A., Kawano M., Namba Y., Kawakami M., Ikeda K. A high frequency of apolipoprotein E4 isoprotein in Japanese patients with late-onset nonfamilial Alzheimer's disease. Neurosci Lett. 1993 Dec 12;163(2):166–168. doi: 10.1016/0304-3940(93)90373-s. [DOI] [PubMed] [Google Scholar]
  122. Van Broeckhoven C., Backhovens H., Cruts M., De Winter G., Bruyland M., Cras P., Martin J. J. Mapping of a gene predisposing to early-onset Alzheimer's disease to chromosome 14q24.3. Nat Genet. 1992 Dec;2(4):335–339. doi: 10.1038/ng1292-335. [DOI] [PubMed] [Google Scholar]
  123. Van Broeckhoven C., Backhovens H., Cruts M., Martin J. J., Crook R., Houlden H., Hardy J. APOE genotype does not modulate age of onset in families with chromosome 14 encoded Alzheimer's disease. Neurosci Lett. 1994 Mar 14;169(1-2):179–180. doi: 10.1016/0304-3940(94)90385-9. [DOI] [PubMed] [Google Scholar]
  124. Van Broeckhoven C., Genthe A. M., Vandenberghe A., Horsthemke B., Backhovens H., Raeymaekers P., Van Hul W., Wehnert A., Gheuens J., Cras P. Failure of familial Alzheimer's disease to segregate with the A4-amyloid gene in several European families. Nature. 1987 Sep 10;329(6135):153–155. doi: 10.1038/329153a0. [DOI] [PubMed] [Google Scholar]
  125. Van Broeckhoven C., Haan J., Bakker E., Hardy J. A., Van Hul W., Wehnert A., Vegter-Van der Vlis M., Roos R. A. Amyloid beta protein precursor gene and hereditary cerebral hemorrhage with amyloidosis (Dutch). Science. 1990 Jun 1;248(4959):1120–1122. doi: 10.1126/science.1971458. [DOI] [PubMed] [Google Scholar]
  126. WHEELAN L. Familial Alzheimer's disease. Ann Hum Genet. 1959 Jul;23:300–310. doi: 10.1111/j.1469-1809.1959.tb01473.x. [DOI] [PubMed] [Google Scholar]
  127. Wasco W., Bupp K., Magendantz M., Gusella J. F., Tanzi R. E., Solomon F. Identification of a mouse brain cDNA that encodes a protein related to the Alzheimer disease-associated amyloid beta protein precursor. Proc Natl Acad Sci U S A. 1992 Nov 15;89(22):10758–10762. doi: 10.1073/pnas.89.22.10758. [DOI] [PMC free article] [PubMed] [Google Scholar]
  128. Wasco W., Gurubhagavatula S., Paradis M. D., Romano D. M., Sisodia S. S., Hyman B. T., Neve R. L., Tanzi R. E. Isolation and characterization of APLP2 encoding a homologue of the Alzheimer's associated amyloid beta protein precursor. Nat Genet. 1993 Sep;5(1):95–100. doi: 10.1038/ng0993-95. [DOI] [PubMed] [Google Scholar]
  129. Weidemann A., König G., Bunke D., Fischer P., Salbaum J. M., Masters C. L., Beyreuther K. Identification, biogenesis, and localization of precursors of Alzheimer's disease A4 amyloid protein. Cell. 1989 Apr 7;57(1):115–126. doi: 10.1016/0092-8674(89)90177-3. [DOI] [PubMed] [Google Scholar]
  130. Wisniewski T., Frangione B. Apolipoprotein E: a pathological chaperone protein in patients with cerebral and systemic amyloid. Neurosci Lett. 1992 Feb 3;135(2):235–238. doi: 10.1016/0304-3940(92)90444-c. [DOI] [PubMed] [Google Scholar]
  131. Yoshioka K., Miki T., Katsuya T., Ogihara T., Sakaki Y. The 717Val----Ile substitution in amyloid precursor protein is associated with familial Alzheimer's disease regardless of ethnic groups. Biochem Biophys Res Commun. 1991 Aug 15;178(3):1141–1146. doi: 10.1016/0006-291x(91)91011-z. [DOI] [PubMed] [Google Scholar]
  132. Yoshizawa T., Yamakawa-Kobayashi K., Komatsuzaki Y., Arinami T., Oguni E., Mizusawa H., Shoji S., Hamaguchi H. Dose-dependent association of apolipoprotein E allele epsilon 4 with late-onset, sporadic Alzheimer's disease. Ann Neurol. 1994 Oct;36(4):656–659. doi: 10.1002/ana.410360416. [DOI] [PubMed] [Google Scholar]
  133. Yu C. E., Payami H., Olson J. M., Boehnke M., Wijsman E. M., Orr H. T., Kukull W. A., Goddard K. A., Nemens E., White J. A. The apolipoprotein E/CI/CII gene cluster and late-onset Alzheimer disease. Am J Hum Genet. 1994 Apr;54(4):631–642. [PMC free article] [PubMed] [Google Scholar]
  134. de Sauvage F., Octave J. N. A novel mRNA of the A4 amyloid precursor gene coding for a possibly secreted protein. Science. 1989 Aug 11;245(4918):651–653. doi: 10.1126/science.2569763. [DOI] [PubMed] [Google Scholar]
  135. van Duijn C. M., Hendriks L., Farrer L. A., Backhovens H., Cruts M., Wehnert A., Hofman A., Van Broeckhoven C. A population-based study of familial Alzheimer disease: linkage to chromosomes 14, 19, and 21. Am J Hum Genet. 1994 Oct;55(4):714–727. [PMC free article] [PubMed] [Google Scholar]
  136. van Duijn C. M., de Knijff P., Cruts M., Wehnert A., Havekes L. M., Hofman A., Van Broeckhoven C. Apolipoprotein E4 allele in a population-based study of early-onset Alzheimer's disease. Nat Genet. 1994 May;7(1):74–78. doi: 10.1038/ng0594-74. [DOI] [PubMed] [Google Scholar]
  137. van Duinen S. G., Castaño E. M., Prelli F., Bots G. T., Luyendijk W., Frangione B. Hereditary cerebral hemorrhage with amyloidosis in patients of Dutch origin is related to Alzheimer disease. Proc Natl Acad Sci U S A. 1987 Aug;84(16):5991–5994. doi: 10.1073/pnas.84.16.5991. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES

  NODES
Association 9
COMMUNITY 2
twitter 2